Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-2.23%
|
$29,232
$42.93 P/Share
|
|
Jun 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,762
+5.35%
|
-
|
|
Jun 01
2021
|
Edward F Mackey EVP, Operations |
SELL
Open market or private sale
|
Direct |
68,173
-74.19%
|
$2,863,266
$42.71 P/Share
|
|
Jun 01
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,319
-26.22%
|
$55,398
$42.93 P/Share
|
|
Jun 01
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,973
+37.15%
|
-
|
|
May 28
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Open market or private sale
|
Direct |
78,192
-31.91%
|
$3,284,064
$42.59 P/Share
|
|
May 14
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
34,965
-1.65%
|
-
|
|
May 06
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
12,000
-4.79%
|
-
|
|
May 06
2021
|
Nelda J Connors Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,098
+16.03%
|
-
|
|
May 06
2021
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,202
+8.6%
|
-
|
|
May 06
2021
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,763
+10.43%
|
-
|
|
May 06
2021
|
David J Roux Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,763
+6.85%
|
-
|
|
May 06
2021
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,763
+11.46%
|
-
|
|
May 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
605
-3.28%
|
$26,015
$43.6 P/Share
|
|
May 01
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,061
+10.06%
|
-
|
|
Apr 30
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
2,358
-1.31%
|
-
|
|
Apr 30
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
13,750
-7.09%
|
$591,250
$43.72 P/Share
|
|
Apr 30
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Bona fide gift
|
Direct |
1,786
-3.81%
|
-
|
|
Apr 30
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
3,572
-7.07%
|
$153,596
$43.51 P/Share
|
|
Apr 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
48,439
-25.82%
|
$2,082,877
$43.98 P/Share
|
|
Apr 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
48,439
+20.52%
|
$339,073
$7.39 P/Share
|
|
Apr 15
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
28,123
-16.81%
|
$1,124,920
$40.95 P/Share
|
|
Apr 15
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
28,123
+14.39%
|
$168,738
$6.28 P/Share
|
|
Apr 15
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
9,676
-24.76%
|
$387,040
$40.0 P/Share
|
|
Apr 15
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+9.81%
|
$55,250
$13.08 P/Share
|
|
Apr 01
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.17%
|
$26,600
$38.61 P/Share
|
|
Mar 16
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
7,603
-78.71%
|
$296,517
$39.36 P/Share
|
|
Mar 03
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,779
-0.7%
|
$67,602
$38.82 P/Share
|
|
Mar 03
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,603
+1.41%
|
-
|
|
Mar 03
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
12,127
-4.4%
|
$460,826
$38.69 P/Share
|
|
Mar 02
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
9,475
-3.33%
|
$360,050
$38.84 P/Share
|
|
Mar 02
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,360
-12.34%
|
$51,680
$38.9 P/Share
|
|
Feb 28
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-0.69%
|
$75,544
$38.78 P/Share
|
|
Feb 28
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+1.54%
|
-
|
|
Feb 28
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-0.25%
|
$18,202
$38.78 P/Share
|
|
Feb 28
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,629
+0.83%
|
-
|
|
Feb 28
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-1.97%
|
$15,922
$38.78 P/Share
|
|
Feb 28
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+6.3%
|
-
|
|
Feb 28
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
596
-1.68%
|
$22,648
$38.78 P/Share
|
|
Feb 28
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,528
+4.14%
|
-
|
|
Feb 28
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-1.17%
|
$41,192
$38.78 P/Share
|
|
Feb 28
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,444
+2.56%
|
-
|
|
Feb 28
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,130
-0.38%
|
$308,940
$38.78 P/Share
|
|
Feb 28
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,330
+0.86%
|
-
|
|
Feb 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-0.66%
|
$35,302
$38.78 P/Share
|
|
Feb 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,037
+1.43%
|
-
|
|
Feb 28
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
235
-0.63%
|
$8,930
$38.78 P/Share
|
|
Feb 28
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
815
+2.14%
|
-
|
|
Feb 28
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.91%
|
$11,362
$38.78 P/Share
|
|
Feb 28
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,018
+3.01%
|
-
|